Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)
The summary for the Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24): -Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes on Health, encourages Research Project Grant (R24) applications from institutions that historically and/or currently serve students from diverse and disadvantaged backgrounds that aim to increase their capacity to conduct drug abuse and addiction research. The applications should propose to foster the research career development of a diverse cadre of faculty, students and staff who are currently underrepresented in drug abuse research, and to enhance research infrastructure at the institution.-Mechanism of Support. This FOA utilizes the R24 mechanism. -Funds Available and Anticipated Number of Awards. Funding is available in the amount of up to $350,000 per year in direct costs. The number of awards supported will depend on the number and scientific merit of the proposals received.
Federal Grant Title: | Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Education |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-09-011 |
Type of Funding: | Grant |
CFDA Numbers: | 93.279 |
CFDA Descriptions: | Drug Abuse and Addiction Research Programs |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Jul 15, 2011 |
Posted Date: | Oct 21, 2008 |
Creation Date: | Dec 03, 2008 |
Archive Date: | Dec 04, 2008 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification) Private institutions of higher education Public and State controlled institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
- • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
- • Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - C...
- • Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not ...
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
- • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- • Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...